MGH researchers studying early onset celiac disease

A collaborative group of researchers has identified substantial microbial changes in the intestines of at-risk infants before disease onset in a new, long-term, prospective approach to the development of celiac disease. Using advanced genomic sequencing techniques, MassGeneral Hospital for Children (MGHfC) researchers, along with colleagues from institutions in Italy and the University of Maryland, College… Read More »

Stay Summer Hydrated!

Summer is here and it is more important than ever to stay hydrated. Increasing water intake can often feel boring. “When I was a child, I thought the “adult drink” was coffee. When I became a teenager, I thought the “adult drink” was beer. As an adult, I’ve realized the “adult drink” is in fact…… Read More »

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

Healthcanal.com

Healthcanal.comhttps://www.healthcanal.com Healthcare and Wellness Informative SourceTue, 20 Jul 2021 10:24:32 +0000en-US hourly 1 https://wordpress.org/?v=5.7.2https://www.healthcanal.com/wp-content/uploads/2021/01/logo-02-1.pngHealthcanal.comhttps://www.healthcanal.com 3232Sol CBD Review 2021 & Coupon Code – Is it worth?https://www.healthcanal.com/reviews/sol-cbd Mon, 19 Jul 2021 10:20:00 +0000https://www.healthcanal.com/?post_type=single_reviews&p=267405 9.0 Quality 8.7 Reputation Features Fast delivery 60-day money-back guarantee 100% satisfaction guaranteed Rewards program Full-spectrum CBD oil Tested multiple times by a third-party… Read More »